
FDA Approves First Gene Therapy for Inherited Deafness
The U.S. Food and Drug Administration has approved the first gene therapy designed to restore hearing in children with a rare form of inherited deafness. This breakthrough offers new hope for those affected by congenital hearing loss.
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (71/100)Sources
New Gene Therapy Enables Children With a Rare Form of Deafness to Hear
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.
By Gina Kolata
Read full article →First gene therapy for deafness approved by the FDA
The FDA has approved the first gene therapy that can restore hearing to people who were born with a rare form deafness.
By Rob Stein
Read full article →Can gene therapy restore hearing in children with inherited deafness? What FDA approval means
FDA approves first gene therapy for inherited deafness, targeting OTOF mutations.
Read full article →Regeneron wins FDA approval for hearing loss therapy
Read full article →Researchers achieve breakthrough in gene therapy for congenital deafness - China Daily
Researchers achieve breakthrough in gene therapy for congenital deafness China Daily
Read full article →
